Cardiac pt 3 Flashcards
(71 cards)
why are nitrates used to treat chronic HF
to reduce preload
how does the diuretic effect with SGLT-2 inhibitors occur
through inc loss of Na and glucose -> osmosis leading to dec circulating volume + reduced preload
why are beta blockers used to treat chronic HF
to protect heart from effects of sympathetic overstimulation
for acute HF, what will the drugs used usually seek to do
increase force of contraction
what are the two aims of chronic HF treatment
reduce symptoms
reduce workload on heart
what do BNP peptides do
reduce volume overload by inc urinary excretion of sodium and water
why are angiotensin receptor neprilysis inhibitors (ARNI) used to treat chronic HF
to reduce peripheral resistance and venous return (pre and afterload)
what is HF
heart unable to pump sufficiently to maintain blood flow to supply body’s O2 requirement
whats the electrical effect of cardiac glycosides
dec HR
dec AV conduction
why are sodium-glucose transport inhibitor diuretics used to treat chronic HF
to reduce blood volume (preload)
in vascular SM, inc of cAMP or cGMP causes what
relaxation of BVs
why would you used ivabradine for HF symptoms
if your pt has a HR over than 77bpm
what are two symptoms of excessive congestion
oedema
dyspnea
how does digoxin cause inc Ca
intracellular levels
The poisoning of Na-K-ATPase pump by digoxin leads to increased intracellular sodium levels and this decreases the activity of the Na-Ca exchanger – ultimately leading to increased intracellular calcium levels
what are 3 drug classes used for HF
cardiac glycosides (chronic HF)
phosphodiesterase inhibitors (acute HF)
adrenergic agonists (acute HF)
how do you treat an overdose of cardiac glycosides
administration of neutralizing anti-digoxin antibody fragments (Digibind)
why would you used hydralazine and nitrates for HF symptoms
if ARNI, ACEi, ARBs
not tolerated
why is there limited use of Beta agonists
due to adverse effects and short half life
why are loop diuretics used to treat chronic HF
to reduce pulmonary or peripheral oedema
dapagliflozin
empaglifozin
canaglifozin are examples of what kind of drug
SGLT-2 inhibitors
what are the initial therapies to treat patients with HF symptoms and a reduced EF
ARNI, ACEi, ARBs
Beta blockers
MRAs
SGLTi
what are the two mechanisms of action for cardiac glycosides
blocks Na/K ATPase
results in inc intracellular Ca levels
why are neprilysin inhibitors used with an AngII receptor blockers?
to prevent unwanted increases in AngII